Showing results (21-30 of 238) with videos related to
Sort By:
Pageof 24
Seminars in Oncology|October 19, 2004
Molecular approach to breast cancer treatmentYosef Yarden, José Baselga, David MilesNature Reviews. Clinical Oncology|March 6, 2013
Emerging targeted agents in metastatic breast cancerDimitrios Zardavas, José Baselga, Martine PiccartNature Reviews. Cancer|December 2, 2004
Gefitinib--a novel targeted approach to treating cancerRoy S Herbst, Masahiro Fukuoka, José BaselgaCell|February 11, 2017
Implementing Genome-Driven OncologyDavid M Hyman, Barry S Taylor, José BaselgaThe Oncologist|September 15, 2006
Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancerJosé Baselga, Edith A Perez, Tadeusz Pienkowski, et al.Breast Cancer Research : BCR|May 24, 2011
Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanismGloria Fuentes, Maurizio Scaltriti, José Baselga, et al.Critical Reviews in Oncology/Hematology|October 19, 2017
Advances in the management of HER2-positive early breast cancerJosé Baselga, Robert E Coleman, Javier Cortés, et al.Journal of Proteomics|June 18, 2013
An effect size filter improves the reproducibility in spectral counting-based comparative proteomicsJosep Gregori, Laura Villarreal, Alex Sánchez, et al.Cancer Research|February 24, 2011
p95HER2 and breast cancerJoaquín Arribas, José Baselga, Kim Pedersen, et al.Pageof 24